Beacon SiteUpdate – Myeloma Beacon Launches Opinion Section

The Myeloma Beacon is pleased to announce the addition of an opinion section to its website.
In the opinion section, patients, caregivers, and others with an interest in myeloma have the opportunity to share their views on myeloma-related topics. These may include, among others, an opinion on a topic, a call to action, or tips/advice for myeloma patients.
“We recognize that myeloma patients, caregivers, and others with an interest in the disease have the desire to voice their opinion on important myeloma-related topics,” said Boris Simkovich, publisher of The Myeloma Beacon. “With the launch of the Opinion section, we give our readers the possibility to share their opinions with the broader myeloma community.”
The first opinion piece is written by Carole Giampalmi, who has been diagnosed with smoldering myeloma. Her article calls on people with monoclonal gammopathy of undetermined significance or smoldering myeloma to participate in studies that investigate the progression of these diseases to multiple myeloma.
More articles are scheduled for publication in the coming weeks.
Readers who have signed up to receive Beacon news articles by email will not automatically receive copies of opinion articles. However, anyone who would like to receive an emailed copy of each opinion piece can email their request to .
If you are interested in contributing an article for publication in the opinion section of The Myeloma Beacon, guidelines can be requested by emailing .
Related Articles:
- Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2018)
- Could A Decades-Old Antibiotic Have Anti-Myeloma Activity?
- Getting To Know: Tiragolumab
- Dr. Christoph Driessen On Nelfinavir In The Treatment Of Multiple Myeloma
- FDA Approves Once-Weekly Dosing And Revised Safety Information For Kyprolis